Media contributions
1Media contributions
Title Budesonide 'beneficial' for risky patients with mild COVID-1 Degree of recognition National Media name/outlet Australian Doctor Media type Web Country/Territory Australia Date 16/02/22 Description Inhaled budesonide remains a useful option for treating symptoms of mild COVID-19 despite the advent of new oral antivirals, the RACGP’s quality care spokesman says. Producer/Author Antony Scholefield URL https://www.ausdoc.com.au/news/budesonide-beneficial-risky-patients-mild-covid19 Persons Mark Morgan